[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

Biden’s ‘Test o Treat’ Plan A Windfall For Pfizer, Merck — But Bad For Patients, Doctors Say

By CDM Staff

March 4, 2022

No Comments

Please Follow us on Gab, Minds, Telegram, Rumble, Gab TV, GETTR

President Biden on Tuesday announced a new “Test to Treat” initiative during his State of the Union address which will allow Americans who test positive for COVID-19 at a pharmacy to obtain free antiviral pills “on the spot.”

Biden said the new initiative is a key part of a revamped national strategy to return the country to normal.

But what he didn’t say is that the initiative is also a windfall for pharmaceutical companies like Pfizer and Merck...

To read more visit Children's Health Defense.

CDMedia is being targeted and obviously too effective! We need your support to put more reporters in the field! Help us here!

SHARE THIS ARTICLE

Author

CDM Staff

The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."